R. Hotchkiss and I. Karl, The Pathophysiology and Treatment of Sepsis, New England Journal of Medicine, vol.348, issue.2, pp.138-150, 2003.
DOI : 10.1056/NEJMra021333

Y. Kang and R. Williams, Endotoxin-induced endothelial injury and subendothelial accumulation of fibronectin in rat aorta, The Anatomical Record, vol.73, issue.1, pp.86-102, 1991.
DOI : 10.1002/ar.1092290110

J. Young, J. Headrick, and R. Berne, Endothelial-dependent and independent responses in the thoracic aorta during endotoxic shock, Circ Shock, vol.35, pp.25-30, 1991.

J. Parker and H. Adams, Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia, Circulation Research, vol.72, issue.3, pp.539-551, 1993.
DOI : 10.1161/01.RES.72.3.539

M. Reidy and D. Bowyer, Scanning electron microscopy: Morphology of aortic endothelium following injury by endotoxin and during subsequent repair, Atherosclerosis, vol.26, issue.3, pp.319-328, 1977.
DOI : 10.1016/0021-9150(77)90084-3

M. Lee, G. Schuessler, and S. Chien, Time dependent effects of endotoxin on the ultrastructure of the aortic endothelium, Artery, vol.15, pp.71-89, 1988.

J. Leclerc, Q. Pu, D. Corseaux, E. Haddad, C. Decoene et al., A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state, Critical Care Medicine, vol.28, issue.11, pp.3672-3678, 2000.
DOI : 10.1097/00003246-200011000-00023

E. Abraham, Effects of Recombinant Human Activated Protein C in Human Models of Endotoxin Administration, Proceedings of the American Thoracic Society, vol.2, issue.3, pp.243-250, 2005.
DOI : 10.1513/pats.200501-004AC

E. Wiel, Q. Pu, D. Corseaux, R. E. Bordet, R. Lund et al., Effect of L-arginine on endothelial injury and hemostasis in rabbit endotoxin shock, J Appl Physiol, vol.89, pp.1811-1818, 2000.

Q. Pu, E. Wiel, D. Corseaux, R. Bordet, M. Azrin et al., Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock, Critical Care Medicine, vol.29, issue.6, pp.1181-1188, 2001.
DOI : 10.1097/00003246-200106000-00019

E. Wiel, Q. Pu, J. Leclerc, D. Corseaux, R. Bordet et al., Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock, Intensive Care Medicine, vol.30, issue.8, pp.1652-1659, 2004.
DOI : 10.1007/s00134-004-2198-4

E. Wiel, G. Lebuffe, E. Robin, G. Gasan, D. Corseaux et al., Pretreatment with peroxysome proliferator-activated receptor ?? agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock, Intensive Care Medicine, vol.40, issue.9, pp.1269-1279, 2005.
DOI : 10.1007/s00134-005-2730-1

E. Wiel and B. Vallet, The Endothelium in Intensive Care, Critical Care Clinics, vol.21, issue.3, pp.403-416, 2005.
DOI : 10.1016/j.ccc.2005.03.001

C. Esmon, The protein C anticoagulant pathway, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.12, issue.2, pp.135-145, 1992.
DOI : 10.1161/01.ATV.12.2.135

M. Riewald and W. Ruf, Science review Role of coagulation protease cascades in sepsis, Critical Care, vol.7, issue.2, pp.123-129, 2003.
DOI : 10.1186/cc1825

S. Yan, J. Helterbrand, D. Hartman, T. Wright, and G. Bernard, Low Levels of Protein C Are Associated With Poor Outcome in Severe Sepsis, Chest, vol.120, issue.3, pp.915-922, 2001.
DOI : 10.1378/chest.120.3.915

J. Hoffmann, B. Vollmar, M. Laschke, D. Inthorn, J. Fertmann et al., Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia*, Critical Care Medicine, vol.32, issue.4, pp.1011-1017, 2004.
DOI : 10.1097/01.CCM.0000120058.88975.42

C. Jackson, B. Bailey, and T. Shetler, Pharmacological profile of recombinant human activated protein C (LY203638) in a canine model of coronary artery thrombosis, J Pharmacol Exp Ther, vol.295, pp.967-971, 2000.

M. Hamon, B. Vallet, C. Bauters, N. Wernert, E. Mcfadden et al., Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury, Circulation, vol.90, issue.3, pp.1357-1362, 1994.
DOI : 10.1161/01.CIR.90.3.1357

S. Carson, Continuous chromogenic tissue factor assay: Comparison to clot-based assays and sensitivity established using pure tissue factor, Thrombosis Research, vol.47, issue.4, pp.379-387, 1987.
DOI : 10.1016/0049-3848(87)90453-1

D. Corseaux, L. Tourneau, T. Six, I. Ezekowitz, M. et al., Enhanced Monocyte Tissue Factor Response After Experimental Balloon Angioplasty in Hypercholesterolemic Rabbit: Inhibition With Dietary L-Arginine, Circulation, vol.98, issue.17, pp.1776-1782, 1998.
DOI : 10.1161/01.CIR.98.17.1776

F. Taylor, A. Chang, C. Esmon, D. Angelo, A. Vigano-d-'angelo et al., Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon., Journal of Clinical Investigation, vol.79, issue.3, pp.918-925, 1987.
DOI : 10.1172/JCI112902

M. Roback, A. Stack, C. Thompson, C. Brugnara, H. Schwartz et al., ACTIVATED PROTEIN C CONCENTRATE FOR THE TREATMENT OF MENINGOCOCCAL ENDOTOXIN SHOCK IN RABBITS, SHOCK, vol.9, issue.2, pp.138-142, 1998.
DOI : 10.1097/00024382-199802000-00011

A. Gruber, J. Griffin, L. Harker, and S. Hanson, Inhibition of platelet-dependent thrombus formation by activated protein C in a primate model, Blood, vol.73, pp.639-642, 1989.

F. Taylor, D. Stearns-kurosawa, S. Kurosawa, G. Ferrell, A. Chang et al., The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis, Blood, vol.95, pp.1680-1686, 2000.

U. Derhaschnig, R. Reiter, P. Knöbl, M. Baumgartner, P. Keen et al., Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia, Blood, vol.102, issue.6, pp.2093-2098, 2003.
DOI : 10.1182/blood-2003-02-0416

U. Hollenstein, M. Homoncik, P. Knöbl, T. Pernerstorfer, J. Graggaber et al., Acenocoumarol decreases tissue factor???dependent coagulation during systemic inflammation in humans, Clinical Pharmacology & Therapeutics, vol.71, issue.5, pp.368-374, 2002.
DOI : 10.1067/mcp.2002.123596

T. Pernerstorfer, U. Hollenstein, J. Hansen, M. Knechtelsdorfer, P. Stohlawetz et al., Heparin Blunts Endotoxin-Induced Coagulation Activation, Circulation, vol.100, issue.25, pp.2485-2490, 1999.
DOI : 10.1161/01.CIR.100.25.2485

E. Dejonge, P. Dekkers, A. Creaseay, C. Hack, S. Paulson et al., Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia, Blood, vol.95, pp.1124-1129, 2000.

B. Grinnell and S. Yan, Novel antithrombotics based on modulation of protein C pathway, Coron Artery Dis, vol.9, pp.89-97, 1998.

F. Shua, H. Kobayashia, K. Fukudome, N. Tsuneyoshib, M. Kimotob et al., Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner, FEBS Letters, vol.83, issue.3, pp.208-212, 2000.
DOI : 10.1016/S0014-5793(00)01740-3

D. Joyce, L. Gelbert, A. Ciacca, B. Dehoff, and B. Grinnell, Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis, Journal of Biological Chemistry, vol.276, issue.14, pp.11199-11203, 2001.
DOI : 10.1074/jbc.C100017200

R. Hotchkiss, K. Tinsley, P. Swanson, and I. Karl, Endothelial cell apoptosis in sepsis, Critical Care Medicine, vol.30, issue.Supplement, pp.225-228, 2002.
DOI : 10.1097/00003246-200205001-00009

T. Cheng, D. Liu, J. Griffin, J. Fernandez, F. Castellino et al., Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective, Nature Medicine, vol.9, issue.3, pp.338-342, 2003.
DOI : 10.1038/nm826

H. Isobe, K. Okajima, M. Uchiba, A. Mizutani, N. Harada et al., Activated Protein C Prevents Endotoxin-Induced Hypotension in Rats by Inhibiting Excessive Production of Nitric Oxide, Circulation, vol.104, issue.10, pp.1171-1175, 2001.
DOI : 10.1161/hc3501.093799

B. Vallet and E. Wiel, Endothelial cell dysfunction and coagulation, Critical Care Medicine, vol.29, pp.36-41, 2001.
DOI : 10.1097/00003246-200107001-00015

M. Riewald and W. Ruf, Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling, Journal of Biological Chemistry, vol.280, issue.20
DOI : 10.1074/jbc.M500747200

X. Monnet, B. Lamia, N. Anguel, C. Richard, G. Bonmarchand et al., Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients, Intensive Care Medicine, vol.33, issue.11, pp.1573-1576, 2005.
DOI : 10.1007/s00134-005-2792-0

A. Bhattacharya, B. Grinnell, and M. Cohen, Unlike thrombin, protein C and activated protein C do not affect vascular tone, Peptides, vol.21, issue.8, pp.1231-1236, 2000.
DOI : 10.1016/S0196-9781(00)00264-3